NOVEMBER - 202219TECH OUTLOOKCLOUD COMPUTING DRIVING CHANGE IN PHARMA INDUSTRYBy Chris Braithwaite, SVP and Global Head of Drug Development Technology, NovartisIn an interview with Pharma Tech Outlook Magazine, Chris Braithwaite discusses the future of cloud disrupting development technology in the pharmaceutical industry.As a dynamic senior technology executive with 20+ years of pharmaceutical experience in strategy delivery, digital transformation, and talent building, how do you see the pharmaceutical industry evolving?The major transition that is currently taking place in the industry is the use of vast amounts of data to drive decision-making regarding the efficacy and safety of products for clinical trials and regulatory submissions. While there have been data-driven initiatives in the past, they usually revolved around fairly discrete data sets. Now, we are seeing much larger data sets being Chris Braithwaite, a dynamic senior technology executive with 20+ years of pharmaceutical experience in strategy delivery, digital transformation and talent building. Proven track record of success in building scaled, high performing teams and managing rapid change, while bringing solid business results through innovative investments in data and technologyCXO INSIGHTS
< Page 9 | Page 11 >